Navigation Links
Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
Date:1/25/2008

discussion of these and other factors, please see the Company's SEC filings, including the disclosure under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

- FINANCIAL INFORMATION TO FOLLOW -

KENSEY NASH CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)

Three Months Six Months

Ended December 31, Ended December 31,

2007 2006 2007 2006

Revenues:

Net sales

Biomaterial sales $11,484,912 $9,971,821 $21,652,211 $19,817,298

Endovascular sales 1,661,951 1,226,295 3,026,181 1,934,007

Total net sales 13,146,863 11,198,116 24,678,392 21,751,305

Royalty income 6,491,062 6,093,938 12,561,950 11,812,083

Total revenues 19,637,925 17,292,054 37,240,342 33,563,388

Operating costs and

expenses:

Cost of products sold 6,177,524 5,261,524 11,821,673 10,109,353

Research and

development 3,959,591 4,814,726 8,891,594 9,190,355

Sales and marketing 3,742,925 3,385,835 7,506,077 6,414,137

General and

administrative 2,186,449 2,045,684 5,999,887 4,105,153

Total operating

costs and expenses 16,066,489 15,507,769 34,219,231 29,818,998

Income from operations 3,571,436 1,784,285 3,021,111 3,744,390

Interest and other

income, net 195,918 235,026 422,262 378,543

'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
3. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
6. Kensey Nash Announces $25 Million Stock Repurchase Program
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. WellPoint Reports Fourth Quarter and Full Year 2007 Results
9. Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
10. TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
11. Health care reform and 2008 elections: New reports examine candidates plans, publics views
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...g the reaction of blood vessels in the eyes may of...w blood vessels in // the brain react to high blo...w study finds the drug candesartan cilexetil, also...in the eye, which can be slowed from the result of...
...estrogen alone will not prevent chronic diseases i.... However it is found to increase // the risk of s...ding to the latest research. For the study investi...ne estrogen alone or in combination with progestin...
... have a brother with prostate cancer are twice as ...udy shows// more men realize this fact and are tak...ompared data from two studies, researchers asked m...are currently taking vitamins or supplements to pr...
...ng waistline is bad for your health, but now a new...or your health.// When a company downsizes, it of...ly, the workers are concerned about their job and ...ngly shows when a company expands quickly, workers...
Other Medicine News:
(Date:8/21/2008)....J. and EMERYVILLE, Calif., Aug. 21 /PRNewswire-Fi... and Onyx Pharmaceuticals, Inc.,(Nasdaq: ONXX ) t...patients,in the STORM Sorafenib as Adjuvant Treatm...lar Carcinoma trial. The randomized, double-blind,...xavar(R) (sorafenib),tablets as adjuvant treatment...
(Date:8/20/2008)...Aug. 20 /PRNewswire-USNewswire/ -- Graduated compr... deep vein thrombosis (DVT) in,hospitalized patien... at,risk for potentially-deadly blood clots, accor...llas., Their findings appear in the September iss...patients are at increased risk for blood clots aft...
(Date:8/19/2008)...M, Pa., Aug. 19 /- Particle Sciences ...uting polymers) development and,pilot production c...,extrusion and injection molding line. The core o...mpounding extruder and Nissei 20T injection,molder...ed polymeric,devices. This addition gives Particle...
(Date:8/18/2008)...WN, Pa., Aug. 18 /PRNewswire-USNewswire/ -- Due to...nfected mosquitoes in,southeastern Pennsylvania, t...county partners will be stepping up efforts this w...- or are most likely to carry -- the virus., Whil...een confirmed,this year (a 27-year-old Montgomery ...
Breaking Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5Dallas Researchers Find Compression Stockings Improperly Used 2Particle Sciences Expands Its Combination Product Capabilities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 1ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 2ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 3TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 1TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 2MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 1MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 1Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 3
...esults show risk of heart attack,comparable to two... , June 6, 2007 - A study,of more than 33,000 ty... published today. This study shows that the incide...r a surgery known as,coronary revascularization fo...iabetes treatments. The study results were,release...
...s lead molecule, FP0011, exhibited a differentiate...rance in mid- to,late-stage patients, STRASBOURG, ... a,clinical stage product company specializing in ...s of the nervous system, today,announced that the ...cule glutamate release inhibitor, FP0011, are bein...
Other Medicine Technology:Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 2Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 3Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 4Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 2Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 3Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 4
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
ManuTrain is an active wrist support that has optional features for increased stabilization.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
3-Point® Polycentric Hinged Ulnar Deviation Splint uses safe, mild to moderate force to align the hand with ulnar deviation at the MP joints. Dorsal-based splint does not impede grasp or pinch. R
Medicine Products: